Avista Healthcare Partners, L.P. - Aug 8, 2022 Form 4 Insider Report for RVL Pharmaceuticals plc (RVLP)

Role
10%+ Owner
Signature
Avista Healthcare Partners GP, Ltd. By: /s/ Ben Silbert, Chief Administrative Officer and General Counsel
Stock symbol
RVLP
Transactions as of
Aug 8, 2022
Transactions value $
$12,400,000
Form type
4
Date filed
8/9/2022, 05:18 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVLP Ordinary Shares Purchase $12.4M +8M +50.86% $1.55 23.7M Aug 8, 2022 Direct F1
holding RVLP Ordinary Shares 1.03M Aug 8, 2022 By Avista Capital investment fund F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of the Issuer held by Avista Healthcare Partners, L.P. ("AHP"). Avista Healthcare Partners GP, Ltd. ("AHP GP") is the general partner of AHP. As a result, AHP GP may be deemed to share voting and investment power with respect to the shares held by AHP. Each of AHP and AHP GP disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.
F2 Represents shares of the Issuer held by Orbit Co-Invest III LLC. Avista Capital Partners III GP, L.P. ("ACP GP") is the manager of Orbit Co-Invest III LLC. As a result, ACP GP may be deemed to share voting and investment power with respect to the shares held by Orbit Co-Invest III LLC. Each of Orbit Co-Invest III LLC and ACP GP disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.